ArticleAnnals of medicine2022

Therapeutic safety and efficacy of triple-immunosuppressants versus dual-immunosuppressants in severe-to-critical COVID-19: a prospective cohort study in Bangladesh.

Md Jahidul Hasan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.